The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...